Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    August 2018
  1. VICKERS A, Ehdaie B
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    


  2. MARTINI A, Cumarasamy S, Tewari AK
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    



  3. MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589-590.
    PubMed     Text format    


    June 2018
  4. RACHNER TD, Tsourdi E, Hofbauer LC
    Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2.
    PubMed     Text format    



  5. Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2542.
    PubMed     Text format    


  6. HUSSAIN M, Fizazi K, Saad F, Rathenborg P, et al
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;378:2465-2474.
    PubMed     Text format     Abstract available


  7. BEAVER JA, Kluetz PG, Pazdur R
    Metastasis-free Survival - A New End Point in Prostate Cancer Trials.
    N Engl J Med. 2018;378:2458-2460.
    PubMed     Text format    


  8. SMITH MR
    Progress in Nonmetastatic Prostate Cancer.
    N Engl J Med. 2018;378:2531-2532.
    PubMed     Text format    


    May 2018
  9. BARRY MJ, Rosenkrantz AB
    MRI-Targeted versus Ultrasonography-Guided Biopsy for Suspected Prostate Cancer.
    N Engl J Med. 2018;378:1835-1836.
    PubMed     Text format    


  10. SMITH TJ, Loprinzi CL, Deville C
    Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.
    N Engl J Med. 2018;378:1745-1746.
    PubMed     Text format    


    April 2018
  11. RODRIGUEZMORENO JF, GarciaDonas J
    Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653.
    PubMed     Text format    


  12. ABATE-SHEN C
    Prostate Cancer Metastasis - Fueled by Fat?
    N Engl J Med. 2018;378:1643-1645.
    PubMed     Text format    



  13. Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653-1654.
    PubMed     Text format    


    March 2018
  14. KASIVISVANATHAN V, Rannikko AS, Borghi M, Panebianco V, et al
    MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018 Mar 18. doi: 10.1056/NEJMoa1801993.
    PubMed     Text format     Abstract available


    February 2018
  15. CHEN D, Ayala GE
    Innervating Prostate Cancer.
    N Engl J Med. 2018;378:675-677.
    PubMed     Text format    


  16. SMITH MR, Saad F, Chowdhury S, Oudard S, et al
    Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018 Feb 8. doi: 10.1056/NEJMoa1715546.
    PubMed     Text format     Abstract available


  17. SARTOR O, de Bono JS
    Metastatic Prostate Cancer.
    N Engl J Med. 2018 Feb 7. doi: 10.1056/NEJMra1701695.
    PubMed     Text format    


    October 2017
  18. FIZAZI K, Chi KN
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1697-8.
    PubMed     Text format    


  19. ISMAILI N, Guessous F
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695-6.
    PubMed     Text format    


  20. TANNOCK IF
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695.
    PubMed     Text format    


  21. DE BONO J, Eisenberger M, Sartor O
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1694-5.
    PubMed     Text format    


  22. JAMES ND, Spears MR, Sydes MR
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1696-7.
    PubMed     Text format    


    September 2017
  23. SHARMA V, Karnes RJ
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1302.
    PubMed     Text format    



  24. Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-1303.
    PubMed     Text format    


  25. WALLIS CJD, Klotz L
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-2.
    PubMed     Text format    


    July 2017
  26. LOGOTHETIS CJ
    Improved Outcomes in Men with Advanced Prostate Cancer.
    N Engl J Med. 2017;377:388-390.
    PubMed     Text format    


  27. HAYMART MR, Miller DC, Hawley ST
    Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
    N Engl J Med. 2017;377:203-206.
    PubMed     Text format    


  28. WILT TJ, Jones KM, Barry MJ, Andriole GL, et al
    Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:132-142.
    PubMed     Text format     Abstract available


    June 2017
  29. PINSKY PF, Prorok PC, Kramer BJ
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2402.
    PubMed     Text format    


  30. WALSH PC
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2401-2.
    PubMed     Text format    


  31. FIZAZI K, Tran N, Fein L, Matsubara N, et al
    Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
    N Engl J Med. 2017 Jun 4. doi: 10.1056/NEJMoa1704174.
    PubMed     Text format     Abstract available


  32. JAMES ND, de Bono JS, Spears MR, Clarke NW, et al
    Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    N Engl J Med. 2017 Jun 3. doi: 10.1056/NEJMoa1702900.
    PubMed     Text format     Abstract available


    March 2017
  33. PINSKY PF, Prorok PC, Kramer BS
    Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
    N Engl J Med. 2017;376:1285-1289.
    PubMed     Text format    



  34. Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding.
    N Engl J Med. 2017;376:897-8.
    PubMed     Text format    


  35. HONG TS, Allen JN, Shellito PC
    Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding.
    N Engl J Med. 2017;376:898.
    PubMed     Text format    


    February 2017
  36. THOMPSON IM JR
    Improved Therapy for PSA Recurrence after Prostatectomy.
    N Engl J Med. 2017;376:484-485.
    PubMed     Text format    


  37. SHIPLEY WU, Seiferheld W, Lukka HR, Major PP, et al
    Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
    N Engl J Med. 2017;376:417-428.
    PubMed     Text format     Abstract available


    January 2017
  38. D'AMICO AV
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:180-1.
    PubMed     Text format    


  39. KELLEHER MH
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:179-80.
    PubMed     Text format    


  40. NOCERA L, Karabon P, Abdollah F
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:178-9.
    PubMed     Text format    


  41. KLOTZ L, Kibel A, et al.
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:178.
    PubMed     Text format    


  42. STAINSBY GD
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:179.
    PubMed     Text format    



  43. 10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:180.
    PubMed     Text format    


    December 2016
  44. HONG TS, Gray PJ, Allen JN, Shellito PC, et al
    Case 39-2016. A 74-Year-Old Man with Rectal Bleeding and a History of Prostate Cancer.
    N Engl J Med. 2016;375:2481-2488.
    PubMed     Text format    


    November 2016
  45. FOULKES WD
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1803.
    PubMed     Text format    


  46. NA R, Xu J, Isaacs WB
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1802-1803.
    PubMed     Text format    



  47. DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1802-1805.
    PubMed     Text format    


  48. MYGATT JG, Osborn DJ
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1803-4.
    PubMed     Text format    


    October 2016
  49. PINSKY P, Prorok P
    More on Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;375:1500-1501.
    PubMed     Text format    



  50. More on Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;375:1500-1501.
    PubMed     Text format    


    September 2016
  51. D'AMICO AV
    Treatment or Monitoring for Early Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format    


  52. DONOVAN JL, Hamdy FC, Lane JA, Mason M, et al
    Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  53. HAMDY FC, Donovan JL, Lane JA, Mason M, et al
    10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  54. PRITCHARD CC, Mateo J, Walsh MF, De Sarkar N, et al
    Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  55. SHOAG JE, Mittal S, Hu JC
    Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;374:1795-6.
    PubMed     Text format    


    February 2016
  56. FOUAD TM
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  57. EBY PR
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  58. GAYLIS FD, Choi J, Kader AK
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:594-5.
    PubMed     Text format    


  59. WELCH HG, Gorski DH, Albertsen PC
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:596.
    PubMed     Text format    


    January 2016
  60. CICCARESE C, Santoni M, Massari F
    Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.
    N Engl J Med. 2016;374:286.
    PubMed     Text format    


  61. GARCIA JA, Sweeney C
    Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.
    N Engl J Med. 2016;374:287.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: